Abstract
Summary Hormonal methods are used by many fertile women who require contraception. They are highly effective, but their use is associated with an increased risk of venous thromboembolism. This report summarizes the recommendations of the Public Health Service of Italy's Piedmont Region for the prescription of hormonal contraception (November 2007) and the results of the Consensus Conference of the Italian National Health Institute on the prevention of thromboembolism related to hormonal contraception (July 2009). Although hormonal contraception increases the relative risk for venous thromboembolism, both documents agreed that the absolute risk remains very small. Assessments of eligibility for hormonal contraception must be based on complete medical history that include medical conditions, drugs used, and family history. Unnecessary medical barriers, such as routine screening for thrombophilia, are not recommended. Most women can safely use hormonal contraception. Physicians and women should discuss the risks, benefits, and uncertainties associated with hormonal contraception so that women will be able to make informed decisions regarding their use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
